Zobrazeno 1 - 10
of 108
pro vyhledávání: '"Peng Bu"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-18 (2024)
Abstract Triple-negative breast cancer (TNBC) has high heterogeneity, poor prognosis, and limited treatment success. Recently, an immunohistochemistry-based surrogate classification for the “Fudan University Shanghai Cancer Center (FUSCC) subtyping
Externí odkaz:
https://doaj.org/article/d01aa0aa50864faa8d8620bab56c76b5
Autor:
Guohui Han, Xiangdong Bai, Feng Li, Li Huang, Yating Hao, Weina Li, Peng Bu, Huanhu Zhang, Xinxin Liu, Jun Xie
Publikováno v:
Heliyon, Vol 10, Iss 1, Pp e23827- (2024)
Increasing evidence has demonstrated the oncogenic roles of long non-coding RNA (lncRNA) hepatocellular carcinoma (HCC)-associated long non-coding RNA (HANR) in the development of HCC and lung cancer; however, the involvement of HANR in triple-negati
Externí odkaz:
https://doaj.org/article/72ab7c81d513402687e15bd540e4e9e4
Publikováno v:
Diagnostic Pathology, Vol 16, Iss 1, Pp 1-8 (2021)
Abstract Background Secretory breast carcinoma is an uncommon subset of breast cancer that usually has a favorable outcome. Although initially described in children, it also occurs in adults where it may metastasize, possibly resulting in death. To d
Externí odkaz:
https://doaj.org/article/349c9a5c2e394ab698ec396d10ec054c
Autor:
Jing Lian MS, En-Wei Xu PhD, Yan-Feng Xi PhD, Hui-Wen Wang MS, Peng Bu MS, Jin-fen Wang BS, Li-Xia Wang BS
Publikováno v:
Technology in Cancer Research & Treatment, Vol 19 (2020)
Purpose: Mutations of PIK3CA have recently been shown to play an important role in the pathogenesis and progression of breast neoplasms. The prevalence of PIK3CA in Chinese breast cancer patients may be underestimated. Therefore, we investigated the
Externí odkaz:
https://doaj.org/article/9dde1134ffc3465ab2f20dc652c1b8a6
Publikováno v:
Protein & Peptide Letters. 30:295-303
Background: Unlike other subtypes of breast cancer, triple negative breast cancer (TNBC) exhibits aggressive and metastatic behaviors and a lack of effective targeted therapeutics. (R)-9bMS, a small-molecule inhibitor of the non-receptor tyrosine kin
Publikováno v:
Structures. 45:685-694
Publikováno v:
ACS Applied Nano Materials. 5:11787-11796
Publikováno v:
Virchows Archiv. 481:13-21
The molecular subtyping of triple-negative breast cancer (TNBC) is critical to guiding individualized patient treatment. In this study, we sought to characterize the clinicopathologic features of TNBC subtypes and to identify correlates of patient su
Publikováno v:
Journal of Solid State Electrochemistry. 26:831-842
Autor:
Ling Xu Yang, Yong Biao Mu, Chao Liu Zeng, Shenglong Zhu, Ying Wang, Chao Fu, Hui Jun Liu, Huan Peng Bu, R. Liu
Publikováno v:
Ceramics International. 47:31772-31779
High-purity and fine CrB powders are firstly synthesized from Cr and B powders in (Na, K)Cl molten salt at 850 °C for 2 h. Then the as-achieved CrB powders are used as precursors to synthesize homogeneous and size-controlled Cr2AlB2 powders in (Na,